Compare BKU & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BKU | STVN |
|---|---|---|
| Founded | 2009 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Containers/Packaging |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.7B |
| IPO Year | 2010 | 2021 |
| Metric | BKU | STVN |
|---|---|---|
| Price | $47.72 | $19.89 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 3 |
| Target Price | ★ $51.58 | $25.67 |
| AVG Volume (30 Days) | ★ 1.1M | 304.7K |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.87% | 0.39% |
| EPS Growth | ★ 14.61 | N/A |
| EPS | ★ 0.83 | N/A |
| Revenue | ★ $21,732,000.00 | N/A |
| Revenue This Year | $16.26 | $9.67 |
| Revenue Next Year | $4.78 | $9.99 |
| P/E Ratio | $57.60 | ★ $27.15 |
| Revenue Growth | ★ 7.45 | N/A |
| 52 Week Low | $34.79 | $12.89 |
| 52 Week High | $52.11 | $28.00 |
| Indicator | BKU | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 47.39 | 64.32 |
| Support Level | $46.22 | $13.58 |
| Resistance Level | $49.02 | $22.00 |
| Average True Range (ATR) | 1.15 | 0.79 |
| MACD | -0.20 | 0.18 |
| Stochastic Oscillator | 12.55 | 84.23 |
BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses. The company also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products including commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.